Harvard Bioscience Revenue and Competitors

Holliston, MA USA

Location

$19.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Harvard Bioscience's estimated annual revenue is currently $750M per year.(i)
  • Harvard Bioscience's estimated revenue per employee is $1,764,706
  • Harvard Bioscience's total funding is $19.5M.

Employee Data

  • Harvard Bioscience has 425 Employees.(i)
  • Harvard Bioscience grew their employee count by -2% last year.

Harvard Bioscience's People

NameTitleEmail/Phone
1
Sr. VP OperationsReveal Email/Phone
2
Regional VP SalesReveal Email/Phone
3
Global VP, Research and DevelopmentReveal Email/Phone
4
General Counsel and Corporation SecretaryReveal Email/Phone
5
VP Global People OperationsReveal Email/Phone
6
SVP SalesReveal Email/Phone
7
VP Sales-Global Distribution & OEMReveal Email/Phone
8
VP Operations, Division Site LeaderReveal Email/Phone
9
EVPReveal Email/Phone
10
VP Global Product ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Harvard Bioscience?

Harvard Bioscience is a global developer, manufacturer and marketer of innovative, enabling tools for drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. HBIO sells approximately 19,000 products to thousands of researchers in 100 countries though its direct sales force, a 1,000-page catalog, various specialty catalogs and a network of distributors, the most notable of which is Amersham Biosciences (formerly APBiotech). HBIO has sales and manufacturing operations in the United States, the United Kingdom, Germany, Austria and Belgium. It also has sales facilities in France and Canada.

keywords:N/A

$19.5M

Total Funding

425

Number of Employees

$750M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Harvard Bioscience News

2022-04-17 - Harvard Bioscience Schedules First Quarter 2022 Earnings Conference Call for May 4, 2022 at 8:00 AM ET -

Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research,...

2022-04-13 - $29.10 Million in Sales Expected for Harvard Bioscience, Inc ...

Analysts expect Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) to post $29.10 million in sales for the current quarter, according to...

2022-04-06 - Harvard Bioscience, Inc. (NASDAQ:HBIO) Expected to Post ...

Harvard Bioscience, Inc. (NASDAQ:HBIO) Expected to Post Earnings of $0.05 Per Share. Posted by admin on Apr 12th, 2022.

2013-12-05 - Layoffs: Harvard Bioscience cuts 13% of workforce

Massachusetts medtech company Harvard Bioscience’s (NSDQ:HBIO) announced today that it plans to cut about 13% of its global workforce, expecting to reap about $2 million in annual savings. Harvard Bioscience plans to focus its efforts and funds on expanding its footprint in China and advancing ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$137.9M4869%N/A
#2
$355.3M8758%N/A